TZA 2209

a steroidal aromatase inhibitor; structure given in first source

Also Known As:

7-mercapto-D-homo-17-oxaandrosta-1,4-dien-3-one; TZA-2209

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hyperplasia 05/01/1996 - "To determine whether the inhibition of estrogen-related effect in the prostate would be of value in the management of benign prostate hyperplasia (BPH), we examined the effect of TZA-2209, a new steroidal aromatase inhibitor, on the prostate in three of six castrated beagles that received 75 mg/week androstenedione. "

1.	Aromatase Inhibitors
2.	Estrogens (Estrogen)
3.	Androstenedione (4 Androstene 3,17 dione)